Cargando…

A CATT Negative Result after Treatment for Human African Trypanosomiasis Is No Indication for Cure

BACKGROUND: Cure after treatment for human African trypanosomiasis (HAT) is assessed by examination of the cerebrospinal fluid every 6 months, for a total period of 2 years. So far, no markers for cure or treatment failure have been identified in blood. Trypanosome-specific antibodies are detectable...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lejon, Veerle, Ngoyi, Dieudonné Mumba, Boelaert, Marleen, Büscher, Philippe
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811173/ https://www.ncbi.nlm.nih.gov/pubmed/20126270 http://dx.doi.org/10.1371/journal.pntd.0000590

Ejemplares similares

Diagnostic Accuracy of Loopamp Trypanosoma brucei Detection Kit for Diagnosis of Human African Trypanosomiasis in Clinical Samples
por: Mitashi, Patrick, et al.
Publicado: (2013)

Innovative digital technologies for quality assurance of diagnosis of human African trypanosomiasis
por: Hasker, Epco, et al.
Publicado: (2018)

Gambiense Human African Trypanosomiasis and Immunological Memory: Effect on Phenotypic Lymphocyte Profiles and Humoral Immunity
por: Lejon, Veerle, et al.
Publicado: (2014)

False Positivity of Non-Targeted Infections in Malaria Rapid Diagnostic Tests: The Case of Human African Trypanosomiasis
por: Gillet, Philippe, et al.
Publicado: (2013)

Trypanosome SL-RNA detection in blood and cerebrospinal fluid to demonstrate active gambiense human African trypanosomiasis infection
por: Ngay Lukusa, Ipos, et al.
Publicado: (2021)

Two-Year Follow-Up of Trypanosoma brucei gambiense Serology after Successful Treatment of Human African Trypanosomiasis: Results of Four Different Sero-Diagnostic Tests
por: Inocencio da Luz, Raquel, et al.
Publicado: (2022)

Cerebrospinal Fluid-Derived Microvesicles From Sleeping Sickness Patients Alter Protein Expression in Human Astrocytes
por: Dozio, Vito, et al.
Publicado: (2019)

A Combined CXCL10, CXCL8 and H-FABP Panel for the Staging of Human African Trypanosomiasis Patients
por: Hainard, Alexandre, et al.
Publicado: (2009)

WHO target product profiles: four diagnostic tests needed in the effort to eliminate African trypanosomiasis
por: Priotto, Gerardo, et al.
Publicado: (2023)

Trypanosome spliced leader RNA for diagnosis of acoziborole treatment outcome in gambiense human African trypanosomiasis: A longitudinal follow-up study
por: Ngay Lukusa, Ipos, et al.
Publicado: (2022)

Human African Trypanosomiasis Diagnosis in First-Line Health Services of Endemic Countries, a Systematic Review
por: Mitashi, Patrick, et al.
Publicado: (2012)

Cost-effectiveness of Algorithms for Confirmation Test of Human African Trypanosomiasis
por: Lutumba, Pascal, et al.
Publicado: (2007)

Performance of Microscopy for the Diagnosis of Malaria and Human African Trypanosomiasis by Diagnostic Laboratories in the Democratic Republic of the Congo: Results of a Nation-Wide External Quality Assessment
por: Mukadi, Pierre, et al.
Publicado: (2016)

Prevalence of Human African Trypanosomiasis in the Democratic Republic of the Congo
por: Mumba, Dieudonne, et al.
Publicado: (2011)

Mortality trends and risk factors in advanced stage-2 Human African Trypanosomiasis: A critical appraisal of 23 years of experience in the Democratic Republic of Congo
por: Kazumba, Léon Mbiyangandu, et al.
Publicado: (2018)

Introducing the TrypanoGEN biobank: A valuable resource for the elimination of human African trypanosomiasis
por: Ilboudo, Hamidou, et al.
Publicado: (2017)

SNPs in IL4 and IFNG show no protective associations with human African trypanosomiasis in the Democratic Republic of the Congo: a case-control study
por: Fataki Asina, Olivier, et al.
Publicado: (2020)

Diagnostic Accuracy of PCR in gambiense Sleeping Sickness Diagnosis, Staging and Post-Treatment Follow-Up: A 2-year Longitudinal Study
por: Deborggraeve, Stijn, et al.
Publicado: (2011)

Improved Models of Mini Anion Exchange Centrifugation Technique (mAECT) and Modified Single Centrifugation (MSC) for Sleeping Sickness Diagnosis and Staging
por: Büscher, Philippe, et al.
Publicado: (2009)

Immune trypanolysis test as a promising bioassay to monitor the elimination of gambiense human African trypanosomiasis
por: Dama, Emilie, et al.
Publicado: (2019)

Human African Trypanosomiasis in a Rural Community, Democratic Republic of Congo
por: Lutumba, Pascal, et al.
Publicado: (2007)

Melarsoprol Sensitivity Profile of Trypanosoma brucei gambiense Isolates from Cured and Relapsed Sleeping Sickness Patients from the Democratic Republic of the Congo
por: Pyana Pati, Patient, et al.
Publicado: (2014)

Isolation of Trypanosoma brucei gambiense from Cured and Relapsed Sleeping Sickness Patients and Adaptation to Laboratory Mice
por: Pyana, Patient Pati, et al.
Publicado: (2011)

Human African trypanosomiasis control: Achievements and challenges
por: Aksoy, Serap, et al.
Publicado: (2017)

Integration of Human African Trypanosomiasis Control Activities into Primary Healthcare Services: A Scoping Review
por: Mulenga, Philippe, et al.
Publicado: (2019)

Performance of clinical signs and symptoms, rapid and reference laboratory diagnostic tests for diagnosis of human African trypanosomiasis by passive screening in Guinea: a prospective diagnostic accuracy study
por: Camara, Oumou, et al.
Publicado: (2023)

Monitoring the elimination of gambiense human African trypanosomiasis in the historical focus of Batié, South–West Burkina Faso
por: Compaoré, Charlie Franck Alfred, et al.
Publicado: (2022)

Human African Trypanosomiasis in the Democratic Republic of the Congo: A Looming Emergency?
por: Hasker, Epco, et al.
Publicado: (2012)

Passive surveillance of human African trypanosomiasis in Côte d’Ivoire: Understanding prevalence, clinical symptoms and signs, and diagnostic test characteristics
por: Koné, Minayégninrin, et al.
Publicado: (2021)

Feasibility of a dried blood spot strategy for serological screening and surveillance to monitor elimination of Human African Trypanosomiasis in the Democratic Republic of the Congo
por: Inocencio da Luz, Raquel, et al.
Publicado: (2021)

Human African Trypanosomiasis in the Kafue National Park, Zambia
por: Squarre, David, et al.
Publicado: (2016)

African trypanosomiasis
por: Morrison, L J, et al.
Publicado: (2011)

Performance of Parasitological and Molecular Techniques for the Diagnosis and Surveillance of Gambiense Sleeping Sickness
por: Mumba Ngoyi, Dieudonné, et al.
Publicado: (2014)

No evidence for association between APOL1 kidney disease risk alleles and Human African Trypanosomiasis in two Ugandan populations
por: Kimuda, Magambo Phillip, et al.
Publicado: (2018)

Cost of a new method of active screening for human African trypanosomiasis in the Democratic Republic of the Congo
por: Snijders, Rian, et al.
Publicado: (2020)

Actigraphy in Human African Trypanosomiasis as a Tool for Objective Clinical Evaluation and Monitoring: A Pilot Study
por: Njamnshi, Alfred K., et al.
Publicado: (2012)

VSGs Expressed during Natural T. b. gambiense Infection Exhibit Extensive Sequence Divergence and a Subspecies-Specific Bias towards Type B N-Terminal Domains
por: So, Jaime, et al.
Publicado: (2022)

Speaker 1: Vibeke Catts, Australia
por: Catts, Vibeke S., et al.
Publicado: (2016)

Specificity of malaria rapid diagnostic tests is affected by Trypanosoma brucei gambiense sleeping sickness
por: Gillet, Philippe, et al.
Publicado: (2012)

Candidate gene polymorphisms study between human African trypanosomiasis clinical phenotypes in Guinea
por: Kaboré, Justin Windingoudi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ip6n4oacuh1l7vp3n2r8k8hp28